Drug discovery platform
BioInvent discovers and designs antibody drugs using its screening and antibody-engineering technology. The company uses this platform to find new drug candidates for its own pipeline and for partners.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
BioInvent International AB is a Swedish biotech company that discovers and develops antibody-based medicines, mainly for cancer. It does not sell consumer products; instead, it creates drug candidates and research tools that are meant to be tested in clinical studies and then licensed or partnered with larger drugmakers. Its work centers on finding antibodies that can help the immune system attack tumors or block signals that cancer cells use to grow.
The company makes money in a few ways. It can receive payments from research collaborations, upfront licensing deals, milestone payments tied to drug development progress, and future royalties if partnered drug candidates reach the market. In some cases, BioInvent also advances its own drug programs, which can create more value if those medicines succeed, but that also means the business depends heavily on long development timelines and scientific results.
What makes BioInvent different is that it sits at the early discovery stage of the drug chain. Instead of manufacturing finished medicines at scale, it focuses on finding promising antibody candidates and then handing them to partners or pushing them through clinical testing itself. Its main customers and counterparties are pharmaceutical companies, research partners, and the healthcare system that would eventually use any approved cancer drugs it helps create.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
New to Alpha Spread? Create free account
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more